THE Malaysian Society of Infection Control & Infectious Diseases (MyICID) expressed its concern regarding the use of Ivermectin as prophylaxis and a treatment option for COVID-19, without the endorsement of any clinical guideline locally or even internationally.
Being an anti-parasitic drug, Ivermectin is known to have good efficacy and a safe-to-use profile. When combined with laboratory evidence, anecdotal reports and several early clinical trial results, Ivermectin doesn’t break a sweat in appearing as a potential repurposed drug for COVID-19 prevention and treatment.
However, MyICID are hoping to see results from well designed, large randomised controlled trials before determining the efficacy and safety of Ivermectin in COVID-19.
“To date, there are more than 80 randomised controlled trials on Ivermectin which are either completed or ongoing around world. Malaysia is conducting a similar clinical trial involving 500 high risk COVID-19 subjects.
“The results from these trials will yield robust scientific evidence, on not only on the role of Ivermectin in COVID-19 treatment, but also on the optimal dose and duration needed for effective outcomes without causing any adverse effects to the patients,” MyICID president Dr Anusha Shunmugarajoo informed.
That in mind, MyICID voiced its agreement with several health organisations and authorities, including Malaysia’s won Ministry of Health (MOH), on recommending the use of Ivermectin only within the setting of clinical trials.
“This recommendation will ensure the safety of patient whist evaluating the effectiveness of Ivermectin in COVID-19,” Anusha said, adding the disagreement that Ivermectin is a ‘miracle drug’ as the evidence is controversial.
She also opined that such sentiments can lead to misuse and illegal profiteering of Ivermectin, which may bring harm to the people.
“There have been reports of people acquiring Ivermectin from illegitimate sources or consuming Ivermectin meant for animal use, leading to development of adverse effects.
“It is also important to note that Ivermectin interact with other medication and if taken together can lead to detrimental outcomes. As consumers, we must exercise our rights and wisdom to understand the risk and benefit of any medication before taking them,” she clarified.
With that, MyICID is urging the public to adhere to the current treatment recommendations by MOH and other international health agencies before making any further assumptions. – June 26, 2021
